SYRS
Price:
$1.515
Market Cap:
$40.49M
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced sol...[Read more]
Industry
Biotechnology
IPO Date
2016-06-30
Stock Exchange
NASDAQ
Ticker
SYRS
According to Syros Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Syros Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), SYRS's Dividend Yield was at its highest in in the December 2019 quarter at 0.05%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Syros Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Syros Pharmaceuticals, Inc. (SYRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Syros Pharmaceuticals, Inc.’s Dividend Yield is less than Surrozen, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Keros Therapeutics, Inc. (0%), less than Kezar Life Sciences, Inc. (0%), less than IDEAYA Biosciences, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Xencor, Inc. (0%), less than REGENXBIO Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Homology Medicines, Inc. (0%), less than Harpoon Therapeutics, Inc. (0%), less than Passage Bio, Inc. (0%), less than Pasithea Therapeutics Corp. (0%), less than Kronos Bio, Inc. (0%), less than Quoin Pharmaceuticals, Ltd. (0%), less than RenovoRx, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Coherus BioSciences, Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $29.60M | |
0% | $24.78M | |
0% | $513.64M | |
0% | $1.97B | |
0% | $40.82M | |
0% | $3.06B | |
0% | $1.63B | |
0% | $1.00B | |
0% | $567.38M | |
0% | $4.03B | |
0% | $305.13M | |
0% | $773.92M | |
0% | $3.02M | |
0% | $865.08M | |
0% | $43.48M | |
0% | $4.37M | |
0% | $59.36M | |
0% | $3.06M | |
0% | $24.47M | |
0% | $71.07M | |
0% | $142.86M | |
0% | $989.87M | |
0% | $8.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syros Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Syros Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Syros Pharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Syros Pharmaceuticals, Inc. (SYRS)?
What is the highest Dividend Yield for Syros Pharmaceuticals, Inc. (SYRS)?
What is the 3-year average Dividend Yield for Syros Pharmaceuticals, Inc. (SYRS)?
What is the 5-year average Dividend Yield for Syros Pharmaceuticals, Inc. (SYRS)?
How does the current Dividend Yield for Syros Pharmaceuticals, Inc. (SYRS) compare to its historical average?